New formulation comprising a betablocker and optionally a cholesterol-lowering agent
A Standard patent application filed on 15 June 2001 credited to Wikstrand, John ; Berglund, Goran

Details

Application number :

2001274766  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

New formulation comprising a betablocker and optionally a cholesterol-lowering agent  

Inventor :

Wikstrand, John ; Berglund, Goran  

Agent name :

Davies Collison Cave  

Address for service :

1 Nicholson Street Melbourne VIC 3000 Australia  

Filing date :

15 June 2001  

Associated companies :

 

Applicant name :

AstraZeneca AB  

Applicant address :

Sodertalje S-151 85 Sweden  

Old name :

 

Original Source :

Go